Cardinal Health Reports Strong Q1 Fiscal 2027 Results and Raises Annual EPS Guidance

Cardinal Health (NYSE: CAH) reported robust first-quarter fiscal year 2027 results, characterized by a 5% revenue increase to $67.5 billion and a significant jump in non-GAAP diluted earnings per share (EPS) of 28% to $3.26. The company's performance was primarily driven by its Pharmaceutical and Specialty Solutions segment, which saw a 6% revenue rise fueled by brand and specialty pharmaceutical sales. Following the strong quarterly performance, Cardinal Health raised its full-year fiscal 2027 non-GAAP EPS guidance to a range of $12.80 to $13.00. The company also successfully completed a $500 million share repurchase program during the quarter, reflecting disciplined capital allocation and strong cash flow generation.

27 articles from 4 sources · updated

Coverage